Literature DB >> 17896926

Solution phase enantioselective recognition and discrimination by electrospray ionization--mass spectrometry: state-of-the-art, methods, and an eye towards increased throughput measurements.

Kevin A Schug1.   

Abstract

A review is given from the stand-point of applying methods utilizing electrospray ionization - mass spectrometry (ESI-MS) for quantitative binding (affinity and selectivity) determinations in small molecule host-guest (receptor-ligand, selector-selectand, etc.) systems. Advantages over more commonly utilized and traditional solution phase approaches, both in the context of developing new chiral selector molecules for separation and purification of enantiomers and in drug discovery applications, are presented. Although the majority of studies employing methods such as host-guest screening, competitive binding, and titrations have focused on large protein-ligand, DNA-ligand, and RNA-ligand systems, the use of ESI-MS for studying small molecule and chiral recognition systems is growing. For the latter case, greater care must be given to considering the effects of the ESI process on the ionization of the species involved in equilibria of interest. Some basic mechanistic and practical concerns for performing solution-phase-targeting quantitative measurements by ESI-MS are given in this light. Finally, an account of the application of these methods in a high throughput format is given, highlighting the potential of traditional and novel screening and titration approaches which allow scientists to screen the performance of hundreds, if not thousands, of compounds in a single day.

Mesh:

Substances:

Year:  2007        PMID: 17896926     DOI: 10.2174/138620707781662790

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  8 in total

1.  Reliable determinations of protein-ligand interactions by direct ESI-MS measurements. Are we there yet?

Authors:  Elena N Kitova; Amr El-Hawiet; Paul D Schnier; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2012-01-21       Impact factor: 3.109

2.  Quantifying labile protein-ligand interactions using electrospray ionization mass spectrometry.

Authors:  Amr El-Hawiet; Elena N Kitova; Lan Liu; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2010-07-29       Impact factor: 3.109

3.  Determination of Noncovalent Binding Using a Continuous Stirred Tank Reactor as a Flow Injection Device Coupled to Electrospray Ionization Mass Spectrometry.

Authors:  Inês C Santos; Veronica B Waybright; Hui Fan; Sabra Ramirez; Raquel B R Mesquita; António O S S Rangel; Petr Fryčák; Kevin A Schug
Journal:  J Am Soc Mass Spectrom       Date:  2015-04-02       Impact factor: 3.109

4.  Quantifying protein-fatty acid interactions using electrospray ionization mass spectrometry.

Authors:  Lan Liu; Elena N Kitova; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2011-02-01       Impact factor: 3.109

5.  On the preservation of non-covalent protein complexes during electrospray ionization.

Authors:  Konstantin Chingin; Konstantin Barylyuk; Huanwen Chen
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2016-10-28       Impact factor: 4.226

6.  Investigation of monovalent and bivalent enantioselective molecular recognition by electrospray ionization-mass spectrometry and tandem mass spectrometry.

Authors:  Kevin A Schug; Manishkumar D Joshi; Petr Frycák; Norbert M Maier; Wolfgang Lindner
Journal:  J Am Soc Mass Spectrom       Date:  2008-07-17       Impact factor: 3.109

7.  Antimony(III)-D, L-tartrates exhibit proton-assisted enantioselective binding in solution and in the gas phase.

Authors:  Aruna B Wijeratne; Sandra E Spencer; Jose Gracia; Daniel W Armstrong; Kevin A Schug
Journal:  J Am Soc Mass Spectrom       Date:  2009-07-19       Impact factor: 3.109

8.  SMMRNA: a database of small molecule modulators of RNA.

Authors:  Ankita Mehta; Surabhi Sonam; Isha Gouri; Saurabh Loharch; Deepak K Sharma; Raman Parkesh
Journal:  Nucleic Acids Res       Date:  2013-10-24       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.